Palyam serogroup VP7 protein antibody and antigen (recombinant protein)

Diagnostic anti-Palyam serogroup VP7 protein antibodies pairs and antigen for animal health (animal Bovines/Cattle infectious disease abortion and teratology) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT

Target products collectionGo to Ruminants disease testing products collection >>


Product information

Catalog No. Description US $ Price (per mg)
GMP-VT-P092-Tg001-Ag01 Recombinant Palyam serogroup VP7 protein protein $3090.00
GMP-VT-P092-Tg001-Ab01 Anti-Palyam serogroup VP7 protein mouse monoclonal antibody (mAb) $3090.00
GMP-VT-P092-Tg001-Ab02 Anti-Palyam serogroup VP7 protein mouse monoclonal antibody (mAb) $3090.00
GMP-VT-P092-Tg001-Ab03 Anti-Palyam serogroup VP7 protein human monoclonal antibody (mAb) $3090.00
GMP-VT-P092-Tg001-Ab04 Anti-Palyam serogroup VP7 protein human monoclonal antibody (mAb) $3090.00

Size: 1mg | 10mg | 100mg



Product Description

Cat No. GMP-VT-P092-Tg001-Ag01
Product Name Recombinant Palyam serogroup VP7 protein protein
Pathogen Palyam serogroup
Expression platform E.coli
Isotypes Recombinant Antigen
Bioactivity validation Anti-Palyam serogroup VP7 protein antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in Palyam serogroup level test of animal Bovines/Cattle infectious disease with abortion and teratology.
Tag His
Product description Recombinant Palyam serogroup VP7 protein proteinwas expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus.
Purity Purity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Cat No. GMP-VT-P092-Tg001-Ab01,GMP-VT-P092-Tg001-Ab02
Pathogen Palyam serogroup
Product Name Anti-Palyam serogroup VP7 protein mouse monoclonal antibody (mAb)
Expression platform CHO
Isotypes Mouse IgG
Bioactivity validation Recombinant Palyam serogroup VP7 protein antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Palyam serogroup antibodies in Palyam serogroup level test of animal Bovines/Cattle infectious disease with abortion and teratology.
Product description Anti-Palyam serogroup VP7 protein mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Palyam serogroup antibodies.
Purity Purity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Cat No. GMP-VT-P092-Tg001-Ab03,GMP-VT-P092-Tg001-Ab04
Pathogen Palyam serogroup
Product Name Anti-Palyam serogroup VP7 protein human monoclonal antibody (mAb)
Expression platform CHO
Isotypes Human lgG1
Bioactivity validation Recombinant Palyam serogroup VP7 protein antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Palyam serogroup antibodies in Palyam serogroup level test of animal Bovines/Cattle infectious disease with abortion and teratology.
Product description Anti-Palyam serogroup VP7 protein mouse monoclonal antibody (mAb) is a human monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair.
Purity Purity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Reference




    Validation Data


    Click to get more Data / Case study about the product.



    Pathogen Information


    In September 2021, the world continued to grapple with the effects of the COVID-19 pandemic. The pandemic, which had emerged in late 2019, had caused a global health crisis, leading to lockdowns, travel restrictions, and a significant loss of life. However, by September 2021, several vaccines had been developed and widely distributed, providing hope for a way out of the crisis. Vaccination campaigns were in progress in many countries, with some achieving relatively high vaccination rates. Nonetheless, there were concerns about vaccine distribution inequalities, vaccine hesitancy, and the emergence of new variants of the virus.

    The pandemic had a profound impact on various aspects of society. Remote work and online education had become more prevalent than ever before, transforming the way people worked and learned. Many businesses were reevaluating their work-from-home policies and considering hybrid models for the future. This shift towards remote work also had implications for urban planning, as some predicted a potential decrease in demand for commercial office space in city centers.

    Another significant issue in September 2021 was climate change. The urgency of addressing climate change and transitioning to a more sustainable global economy had become increasingly apparent. The Intergovernmental Panel on Climate Change (IPCC) released a report that emphasized the need for immediate and drastic action to limit global warming. Governments and corporations were making commitments to reduce carbon emissions, and there was growing interest in renewable energy sources, such as wind, solar, and hydropower.

    Technological advancements continued to drive change in various industries. Artificial intelligence and machine learning were being integrated into a wide range of applications, from self-driving cars to medical diagnostics. Big data and analytics were being used to gain insights into customer behavior, leading to more personalized marketing and product recommendations. Conversational AI and chatbots were becoming more sophisticated, improving customer service and support.

    The space exploration industry was also experiencing a renaissance. Private companies like SpaceX, led by Elon Musk, were making significant strides in reducing the cost of space travel. SpaceX's reusable Falcon rockets and the development of the Starship spacecraft were aiming to make space more accessible and affordable. Similarly, Blue Origin, founded by Jeff Bezos, was focused on expanding human access to space, with plans for suborbital and orbital space tourism.

    Geo-politically, the world was navigating complex issues. The U.S.-China relationship was a topic of considerable concern, with ongoing trade disputes, technology competition, and differences in global influence. In the Middle East, geopolitical tensions persisted, particularly in countries like Afghanistan and Syria. In Europe, Brexit had created economic and political challenges, and the European Union was working to strengthen its unity and address the economic impact of the pandemic.

    Economically, the world was still dealing with the repercussions of the pandemic. Governments had implemented various fiscal stimulus measures to support businesses and individuals affected by lockdowns and economic downturns. Inflation had become a concern in some regions, and central banks were closely monitoring economic indicators.

    In the realm of social issues, there was a continued focus on diversity, equity, and inclusion. Movements like Black Lives Matter had prompted discussions and initiatives aimed at addressing systemic racism. Gender equality and LGBTQ+ rights were also important topics of conversation, with increased advocacy and awareness.

    In summary, September 2021 was a period marked by the ongoing challenges of the COVID-19 pandemic, the urgency of addressing climate change, technological advancements, geopolitical complexities, and a continued focus on social issues. These factors were shaping the world and influencing the direction of global events and developments.



    About GDU


    GDU

    GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.